Literature DB >> 17654703

Multiple cascade effects of oxidative stress on astroglia.

Cherie E Bond1, Susan A Greenfield.   

Abstract

Many neurodegenerative diseases share common underlying features, most prominent of which are dysregulation of calcium homeostasis and reactive astrogliosis, ultimately triggered by oxidative stress. Interestingly, an additional feature of the early response to stress conditions is the upregulation and release of acetylcholinesterase (AChE). This study therefore investigates the link between oxidative stress, calcium influx, gene expression, protein synthesis, and AChE release. We report that, in astroglia and in an immortalized cell line, GH4-halpha7, acute oxidative stress causes influx of extracellular calcium through L-type voltage-gated calcium channels (L-VGCC), followed by increased release of AChE into the extracellular medium. Moreover, rapid and sustained changes in mRNA expression of AChE, L-VGCC, and melastatin-like transient receptor potential 2 (TRPM2) accompany profound suppression of global protein synthesis. Application of L-VGCC blockers selectively reduces stress-induced calcium influx and AChE release, mitigates changes in gene expression, and facilitates recovery from protein synthesis suppression. Although glia exhibit greater sensitivity in their responses, the results are comparable in astroglia and GH4-halpha7 cells, and suggest a generalized and integrated cellular response to stress conditions that characterizes changes observed in neurodegeneration. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17654703     DOI: 10.1002/glia.20547

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  16 in total

1.  TR(I)Pping towards treatment for ischemia.

Authors:  David A Rempe; Takahiro Takano; Maiken Nedergaard
Journal:  Nat Neurosci       Date:  2009-10       Impact factor: 24.884

2.  Oxidative stress in a model of toxic demyelination in rat brain: the effect of piracetam and vinpocetine.

Authors:  Omar M E Abdel-Salam; Yasser A Khadrawy; Neveen A Salem; Amany A Sleem
Journal:  Neurochem Res       Date:  2011-03-30       Impact factor: 3.996

Review 3.  TRPM2 cation channels, oxidative stress and neurological diseases: where are we now?

Authors:  Mustafa Nazıroğlu
Journal:  Neurochem Res       Date:  2010-12-08       Impact factor: 3.996

Review 4.  The trinity of Ca2+ sources for the exocytotic glutamate release from astrocytes.

Authors:  Reno C Reyes; Vladimir Parpura
Journal:  Neurochem Int       Date:  2009-01-08       Impact factor: 3.921

Review 5.  Recent advances in our understanding of neurodegeneration.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2009-06-05       Impact factor: 3.575

6.  SIR-2.1 integrates metabolic homeostasis with the reproductive neuromuscular excitability in early aging male Caenorhabditis elegans.

Authors:  Xiaoyan Guo; L René García
Journal:  Elife       Date:  2014-04-22       Impact factor: 8.140

7.  Systemic lipopolysaccharide-mediated alteration of cortical neuromodulation involves increases in monoamine oxidase-A and acetylcholinesterase activity.

Authors:  Zhi Ming; Caitlin A Wotton; Robert T Appleton; John C Ching; Matthew E Loewen; Grzegorz Sawicki; Lane K Bekar
Journal:  J Neuroinflammation       Date:  2015-02-25       Impact factor: 8.322

8.  Upregulation of alpha7 Nicotinic Receptors by Acetylcholinesterase C-Terminal Peptides.

Authors:  Cherie E Bond; Martina Zimmermann; Susan A Greenfield
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

9.  Additive toxicity of β-amyloid by a novel bioactive peptide in vitro: possible implications for Alzheimer's disease.

Authors:  Sara Garcia-Ratés; Matthew Lewis; Rosemary Worrall; Susan Greenfield
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

Review 10.  Basic mechanisms of neurodegeneration: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Cell Mol Med       Date:  2010-01-11       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.